Literature DB >> 8132363

Bacteraemia due to different groups of beta-haemolytic streptococci: a two-year survey and presentation of a case of recurring infection due to Streptococcus "equisimilis".

S V Nielsen1, H J Kolmos.   

Abstract

We present a 2-year survey of bacteraemic episodes due to beta-haemolytic streptococci and a case of recurring infection due to group C streptococcus, Streptococcus "equisimilis". We found 53 episodes of bacteraemia with beta-haemolytic streptococci. Group A was the most common, followed by groups B, G and C. The proportion of nosocomial cases was the same in all four groups i.e. 24% (neonatal cases excluded). The clinical picture presented by groups C and G streptococcal cases was indistinguishable from that caused by group A streptococci, but patients with group G bacteraemia were older than patients with group A bacteraemia. Obvious clinical foci were more common in group A than group G cases. Disregarding neonatal cases, most patients had predisposing conditions. There was no difference in foci of bacteraemia, predisposing factors, treatment and outcome of disease. The overall mortality was 25%.

Entities:  

Mesh:

Year:  1993        PMID: 8132363     DOI: 10.1007/bf01728913

Source DB:  PubMed          Journal:  Infection        ISSN: 0300-8126            Impact factor:   3.553


  14 in total

1.  Group-C beta-hemolytic streptococcal bacteremia.

Authors:  J Berenguer; I Sampedro; E Cercenado; J Baraia; M Rodríguez-Créixems; E Bouza
Journal:  Diagn Microbiol Infect Dis       Date:  1992-02       Impact factor: 2.803

2.  Increased number of sporadic nosocomial group A streptococcal bacteraemias during a community epidemic.

Authors:  S Strøbaek; O B Jepsen; J Zimakoff; T Rønne
Journal:  J Hosp Infect       Date:  1991-10       Impact factor: 3.926

Review 3.  Beta-haemolytic group A, B, C and G streptococcal septicaemia: a clinical study.

Authors:  K Skogberg; H Simonen; O V Renkonen; V V Valtonen
Journal:  Scand J Infect Dis       Date:  1988

Review 4.  Group G streptococcal neonatal septicaemia: two case reports and a brief review of literature.

Authors:  H Carstensen; C Pers; O Pryds
Journal:  Scand J Infect Dis       Date:  1988

5.  Group C streptococcal bacteremia: analysis of 88 cases.

Authors:  S F Bradley; J J Gordon; D D Baumgartner; W A Marasco; C A Kauffman
Journal:  Rev Infect Dis       Date:  1991 Mar-Apr

6.  Septicemia and endocarditis caused by group G streptococci in a Norwegian hospital.

Authors:  A Bucher; P Gaustad
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1990-04       Impact factor: 3.267

Review 7.  Invasive streptococcal infections in the era before the acquired immune deficiency syndrome: a 10 years' compilation of patients with streptococcal bacteraemia in North Yorkshire.

Authors:  M Barnham
Journal:  J Infect       Date:  1989-05       Impact factor: 6.072

8.  Serious infections due to group G streptoccocci. Report of 15 cases with in vitro-in vivo correlations.

Authors:  K Lam; A S Bayer
Journal:  Am J Med       Date:  1983-10       Impact factor: 4.965

9.  Streptococci and aerococci associated with systemic infection in man.

Authors:  M T Parker; L C Ball
Journal:  J Med Microbiol       Date:  1976-08       Impact factor: 2.472

10.  Group G streptococcal endocarditis and bacteremia.

Authors:  F R Venezio; R M Gullberg; G O Westenfelder; J P Phair; F V Cook
Journal:  Am J Med       Date:  1986-07       Impact factor: 4.965

View more
  3 in total

1.  Delineation of Streptococcus dysgalactiae, its subspecies, and its clinical and phylogenetic relationship to Streptococcus pyogenes.

Authors:  Anders Jensen; Mogens Kilian
Journal:  J Clin Microbiol       Date:  2011-11-09       Impact factor: 5.948

Review 2.  A case of bacteremia caused by Streptococcus dysgalactiae.

Authors:  F Bert; N Lambert-Zechovsky
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1997-04       Impact factor: 3.267

3.  Analysis of a case of recurrent bacteraemia due to group A Streptococcus equisimilis by pulsed-field gel electrophoresis.

Authors:  F Bert; N Lambert-Zechovsky
Journal:  Infection       Date:  1997 Jul-Aug       Impact factor: 3.553

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.